David Walton

Having served as interim CEO since April 2019, Mr. Walton will assume permanent responsibilities for leading the strategic direction of the organization to best serve people living with type 1 diabetes (T1D) and will remain on T1D Exchange’s Board of Directors, which he joined in 2018.

Mr. Walton has more than 25 years of experience in the healthcare industry, with more than half of that time spent in diabetes in commercial leadership positions at several glucose monitoring, insulin delivery and digital health companies where he helped launch 10 innovative medtech products. Most recently, Mr. Walton served as Chief Commercial Officer of QuiO, a remote monitoring digital health start-up focused on improving care plan adherence and outcomes for people with diabetes and other chronic conditions. Through personal and family experience – he has lived with T1D for 24 years and has a nephew also living with the disease – Mr. Walton is deeply committed to improving the standard of care for all those living with the disease.